Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-15-006816)

Filing Details

Accession Number:: 0000899243-15-006816
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-10-16 16:15:42
Reporting Period:: 2015-10-15

Filing Date:: 2015-10-16
Accepted Time:: 2015-10-16 16:15:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1466301	Clovis Oncology Inc.	CLVS	Pharmaceutical Preparations (2834)	900475355

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1268304	C Gillian Ivers-Read	C/O Clovis Oncology, Inc. 2525 28Th Street, Suite 100 Boulder CO 80301	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-10-15	3,000	$91.91	212,583	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2015.